Jatropholone B from Jatropha curcas inhibits melanin synthesis via extracellular signal-regulated kinase activation in Mel-Ab cell

  • Finanda Anwar Harfina ,
  • Seok Park Chang ,
  • Manggau Marianti ,
  • Yun Hye-Young ,
  • Kim Dong-Seok
Expand
  • 1 Department of Biochemistry, Chung-Ang University College of Medicine, Seoul 06974, Republic of Korea
    2 Faculty of Pharmacy, Hasanuddin University, Makassar 90245, Indonesia

Received date: 2022-11-15

  Accepted date: 2023-05-25

  Online published: 2025-05-21

Supported by

Chung-Ang University Young Scientist Scholarship(81603600)

Abstract

OBJECTIVE: In the present study, we investigated the effects of jatropholone B from Jatropha curcas (J. curcas) on melanin synthesis in Mel-Ab cells.
METHODS: Mel-Ab cells were cultured to measure melanin content and tyrosinase activities. Western blotting was performed to investigate jatropholone B-induced signal transduction and measure the expression of melanogenic proteins.
RESULTS: Jatropholone B decreased melanin synthesis in a concentration-dependent manner but did not directly inhibit the activity of tyrosinase, a melanogenic enzyme. Instead, jatropholone B downregulated microphthalmia-associated transcription factor (MITF) and tyrosinase protein levels. Therefore, we investigated jatropholone B-induced signal transduction related to MITF and tyrosinase expression. However, jatropholone B had no significant effect on Akt and glycogen synthase kinase-3β phosphorylation as well as β-catenin change. In contrast, jatropholone B was observed to phosphorylate extracellular signal-regulated kinase (ERK) for the first time. To clarify the involvement of ERK activation in jatropholone B-induced hypopigmentation, we pretreated cells with PD98059, a specific ERK pathway inhibitor, and measured MITF and tyrosinase levels as well as melanin content. PD98059 pretreatment abrogated jatropholone B-induced downregulation of MITF and tyrosinase expression as well as reduction in melanin production.
CONCLUSIONS: Based on these results, we suggest that ERK activation by jatropholone B inhibits melanogenesis via the downregulation of MITF and tyrosinase expression. Therefore, jatropholone B from J. curcas can be a candidate for developing a new skin-whitening agent.

Cite this article

Finanda Anwar Harfina , Seok Park Chang , Manggau Marianti , Yun Hye-Young , Kim Dong-Seok . Jatropholone B from Jatropha curcas inhibits melanin synthesis via extracellular signal-regulated kinase activation in Mel-Ab cell[J]. Journal of Traditional Chinese Medicine, 2025 , 45(3) : 485 -492 . DOI: 10.19852/j.cnki.jtcm.2025.03.005

References

1. Othman AR, Abdullah N, Ahmad S, et al. Elucidation of in-vitro anti-inflammatory bioactive compounds isolated from Jatropha curcas L. plant root. BMC Complement Altern Med 2015; 15: 11.
2. Huang JD, Zhang C, Xu WJ, et al. New lathyrane diterpenoids with anti-inflammatory activity isolated from the roots of Jatropha curcas L. J Ethnopharmacol 2021; 268: 113673.
3. Sabandar CW, Ahmat N, Jaafar FM, Sahidin I. Medicinal property, phytochemistry and pharmacology of several Jatropha species (Euphorbiaceae): a review. Phytochemistry 2013; 85: 7-29.
4. Thomas R, Sah NK, Sharma PB. Therapeutic biology of Jatropha curcas: a mini review. Curr Pharm Biotechnol 2008; 9: 315-24.
5. Liu JQ, Yang YF, Li XY, et al. Cytotoxicity of naturally occurring rhamnofolane diterpenes from Jatropha curcas. Phytochemistry 2013; 96: 265272.
6. Pertino M, Schmeda-Hirschmann G, Rodriguez JA, Theoduloz C. Gastroprotective effect and cytotoxicity of semisynthetic jatropholone derivatives. Planta Medica 2007; 73: 1095-100.
7. D'Mello SA, Finlay GJ, Baguley BC, Askarian-Amiri ME. Signaling pathways in melanogenesis. Int J Mol Sci 2016; 17: 1144.
8. Kim S, Kim M, Choi Y, et al. Down-regulation of tyrosinase, TRP-1, TRP-2 and MITF expressions by citrus press-cakes in murine B16 F10 melanoma. Asian Pac J Trop Biomed 2013; 3: 617-22
9. Sanchez-Ferrer A, Rodriguez-Lopez JN, Garcia-Canovas F, Garcia-Carmona F. Tyrosinase: a comprehensive review of its mechanism. Biochim Biophys Acta 1995; 1247: 1-11.
10. Chen T, Zhao B, Liu Y, et al. MITF-M regulates melanogenesis in mouse melanocytes. J Dermatol Sci 2018; 90: 253-62.
11. Shin JS, Cho JH, Lee H, et al. Dual hypopigmentary effects of punicalagin via the ERK and Akt pathways. Biomed Pharmacother 2017; 92: 122-7.
12. Kim DS, Lee HK, Park SH, et al. Terrein inhibits keratinocyte proliferation via ERK inactivation and G2/M cell cycle arrest. Exp Dermatol 2008; 17: 312-7.
13. Kim DS, Park SH, Kwon SB, et al. Sphingosylphosphorylcholine-induced ERK activation inhibits melanin synthesis in human melanocytes. Pigment Cell Res 2006; 19: 146-53.
14. Kim SY, Hahn HG, Nam KD, et al. A derivative of 2-aminothiazole inhibits melanogenesis in B16 mouse melanoma cells via glycogen synthase kinase 3beta phosphorylation. J Pharm Pharmacol 2011; 63: 1031-6.
15. Bellei B, Flori E, Izzo E, et al. GSK3beta inhibition promotes melanogenesis in mouse B16 melanoma cells and normal human melanocytes. Cell Signal 2008; 20: 1750-61.
16. Kim DS, Park SH, Kwon SB, et al. Sphingosylphosphorylcholine inhibits melanin synthesis via pertussis toxin-sensitive MITF degradation. J Pharm Pharmacol 2010; 62: 181-7.
17. Costin GE, Hearing VJ. Human skin pigmentation: melanocytes modulate skin color in response to stress. FASEB J 2007; 21: 976-94.
18. Solano F. Photoprotection and skin pigmentation: melanin-related molecules and some other new agents obtained from natural sources. Molecules 2020; 25: 1537.
19. Burlando B, Clericuzio M, Cornara L. Moraceae plants with tyrosinase inhibitory activity: a review. Mini Rev Med Chem 2017; 17: 108-21.
20. Kumari S, Tien Guan Thng S, Kumar Verma N, Gautam HK. Melanogenesis Inhibitors. Acta Derm Venereol 2018; 98: 924-31.
21. Kim DS, Hwang ES, Lee JE, et al. Sphingosine-1-phosphate decreases melanin synthesis via sustained ERK activation and subsequent MITF degradation. J Cell Sci 2003; 116: 1699-706.
22. Kim JY, Lee EJ, Ahn Y, et al. A chemical compound from fruit extract of Juglans mandshurica inhibits melanogenesis through p-ERK-associated MITF degradation. Phytomedicine 2019; 57: 57-64.
23. Higuchi K, Kawashima M, Ichikawa Y, Imokawa G. Sphingosylphosphorylcholine is a melanogenic stimulator for human melanocytes. Pigment Cell Res 2003; 16: 670-8.
24. Kim DS, Kim SY, Lee JE, et al. Sphingosine-1-phosphate-induced ERK activation protects human melanocytes from UVB-induced apoptosis. Arch Pharm Res 2003; 26: 739-46.
Outlines

/